FDA’s New Inspections Council Whipping Up Policy Around Remote Regulatory Assessments
Also: Agency carries out more domestic surveillance inspections in FY ’21 than anticipated
Executive Summary
The US FDA says in a report that its Inspectional Affairs Council will develop Remote Regulatory Assessment policies for all commodities the agency oversees. RRAs were launched by the FDA as a way to check on a firm’s regulatory compliance without sending an investigator on-site.
You may also be interested in...
Omicron Forces US FDA To Again Pause ‘Certain Inspectional Activities’
COVID-19 pandemic’s latest variant has pushed FDA to pump brakes again on performing on-site surveillance inspections through at least 19 January. Meanwhile, associate commissioner says Remote Regulatory Assessments “are here to stay.”
Here We Go Again: Omicron Forces FDA To Pause ‘Certain Inspectional Activities’
The COVID-19 pandemic’s latest variant has pushed the US FDA to pump the brake once again on performing on-site surveillance inspections through at least 19 January. Meanwhile, an agency official says Remote Regulatory Assessments “are here to stay.”
‘Regulatory Agility’ Essential For Inspectional Success In A World With COVID-19: FDA Official
The pandemic caused the US FDA’s Office of Regulatory Affairs to consider ways it can be more nimble in its inspectional activities, including launching an agency-wide council to tackle and solve inspection-related issues, the ORA’s Elizabeth Miller says.